J07CA
Bacterial and viral vaccines, combined
Наименование на групата: WHO Collaborating Centre for Drug Statistics Methodology
Подгрупи
ATC класификацията е дърво. Тази категория се разделя на 3 подгрупи.
Лекарствени продукти в тази категория
9 продукта в тази категория и подгрупите ѝ.
| Търговско име | Концентрация |
|---|---|
| Adacel Polio | suspension for injection in pre-filled syringe |
| Boostrix Polio | suspension for injection in pre-filled syringe |
| Hexacima | --¹ One dose¹ (0.5 ml) contains: Diphtheria Toxoid not less than 20 IU (30 Lf) Tetanus Toxoid not less than 40 IU (10 Lf) Bordetella pertussis antigens Pertussis Toxoid 25 micrograms Filamentous Haemagglutinin 25 micrograms Poliovirus (Inactivated) Type 1 (Mahoney) 29 D-antigen units Type 2 (MEF-1) 7 D-antigen units Type 3 (Saukett) 26 D-antigen units Hepatitis B surface antigen 10 micrograms Haemophilus influenzae type b polysaccharide 12 micrograms (Polyribosylribitol Phosphate) conjugated to Tetanus protein 22-36 micrograms ¹ Adsorbed on aluminium hydroxide, hydrated (0.6 mg Al³⁺) |
| Hexyon | --¹ One dose¹ (0.5 ml) contains: Diphtheria Toxoid not less than 20 IU (30 Lf) Tetanus Toxoid not less than 40 IU (10 Lf) Bordetella pertussis antigens Pertussis Toxoid 25 micrograms Filamentous Haemagglutinin 25 micrograms Poliovirus (Inactivated) Type 1 (Mahoney) 29 D-antigen units Type 2 (MEF-1) 7 D-antigen units Type 3 (Saukett) 26 D-antigen units Hepatitis B surface antigen 10 micrograms Haemophilus influenzae type b polysaccharide 12 micrograms (Polyribosylribitol Phosphate) conjugated to Tetanus protein 22-36 micrograms ¹ Adsorbed on aluminium hydroxide, hydrated (0.6 mg Al³⁺) |
| Infanrix hexa | --¹ After reconstitution, 1 dose (0.5 ml) contains: Diphtheria toxoid, adsorbed ≥ 30 IU Tetanus toxoid, adsorbed ≥ 40 IU Pertussis toxoid, adsorbed 25 µg Filamentous haemagglutinin, adsorbed 25 µg Pertactin, adsorbed 8 µg Recombinant hepatitis B surface antigen (S protein), adsorbed 10 µg Inactivated type 1 poliovirus 40 DU Inactivated type 2 poliovirus 8 DU Inactivated type 3 poliovirus 32 DU Conjugate of Haemophilus influenzae type b capsular polysaccharide (PRP) 10 µg and tetanus toxoid (T), adsorbed (PRP-T) approximately 25 µg |
| Infanrix-IPV+Hib | powder and suspension for suspension for injection |
| Pentaxim | powdеr and suspension for suspension for injection |
| Tetraxim | 0,5 ml |
| Vaxelis | --¹ One dose (0.5 ml) contains: Diphtheria Toxoid¹: 15 Lf (≥ 20 IU)⁶ Tetanus Toxoid¹: 5 Lf (≥ 40 IU)⁶ Bordetella pertussis antigens¹: Pertussis Toxoid (PT) 20 micrograms Filamentous Haemagglutinin (FHA) 20 micrograms Pertactin (PRN) 3 micrograms Fimbriae Types 2 and 3 (FIM) 5 micrograms Hepatitis B surface antigen²,³: 10 micrograms Poliovirus (Inactivated)⁴: Type 1 (Mahoney) 29 D antigen units⁵ Type 2 (MEF-1) 7 D antigen units⁵ Type 3 (Saukett) 26 D antigen units⁵ Haemophilus influenzae type b polysaccharide (Polyribosylribitol Phosphate) 3 micrograms Conjugated to meningococcal protein² 50 micrograms ¹ adsorbed on aluminium phosphate (0.17 mg Al³⁺) ² adsorbed on amorphous aluminium hydroxyphosphate sulfate (0.15 mg Al³⁺) ³ produced in yeast (Saccharomyces cerevisiae) cells by recombinant DNA technology ⁴ produced in Vero cells ⁵ These antigen quantities are strictly the same as those previously expressed as 40-8-32 D-antigen units, for virus type 1, 2 and 3 respectively, when measured by another suitable immunochemical method ⁶ or equivalent activity determined by an immunogenicity or antigenicity evaluation. |